LifeStance Health Reports Strong Q2 2025 Results, Raises Full-Year Guidance
LifeStance Health Group Inc. recently held their second quarter 2025 earnings conference call, where the management team, including CEO Dave Bourdon, announced strong financial results. The company achieved double-digit organic revenue growth and 10% adjusted EBITDA margins, prompting an increase in full-year guidance for adjusted EBITDA. LifeStance also reported a record free cash flow of $57 million, reflecting the resilience and differentiation of their patient care model, which offers both in-person and virtual care. The full speech/interview is available on their Investor Relations website. For more details, visit investor.lifestance.com.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LifeStance Health Group Inc. published the original content used to generate this news brief on August 07, 2025, and is solely responsible for the information contained therein.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。